Connect with us

Business

HempAmericana Inc (OTCMKTS:HMPQ) is a Turnaround Prospect

Published

on

Turnaround stories are widely sought and difficult to find, which is why we want to cast a focus on HempAmericana Inc (OTCMKTS:HMPQ) today, as the company positions itself as a long-term beneficiary of the CBD-based products boom – something that has gone undercover so far in 2020 even though it remains possibly one of the most reliably potent large timeframe success stories of the coming decade, according to many prominent analysts.

The big idea here is still unquestionably that of a “mainstreaming” process – the CBD products marketplace is defined by a “small to big” dynamic that is all about a niche product crowd growing into a very widely accepted household goods market. The CBD growth trend that many investors have heard about over the past several years is simply about discovery.

But, even as that process plays out in empirically visible ways, stocks in the space have been carved up due to over-competition.

That said, the sweeping bear market that has ravaged the space has driven many of the less well-founded names into oblivion. Naturally, that’s the point of a bear market: to burn up the excess fat, leaving a leaner, meaner industry to more efficiently monetize the total base of industrial and intellectual capital. It’s the essence of a market-based system.

In this case, HempAmericana Inc (OTCMKTS:HMPQ) is one of the survivors.

As is always the case in such circumstances, the survivors are very deeply undervalued at this point – they’ve been through the ravages of the bear. They’ve been stripped down to nothing. But, at the same time, they’ve also survived to tell the tale. That alone makes them worth a very serious measure of attention. The survivors of a focused bear market in a specific sector often historically represent some of the most powerful opportunities. They are the babies that almost, but not quite, got thrown out with the bathwater. And those are some underpriced babies.

HMPQ belongs to that thematic group right now. The stock is trading at bargain-basement levels in sub-penny territory. But it has real operations and a first-class extraction and production facility in Maine, with ramping resources and a path of very likely tangible top-line growth over the coming period of months. While shareholders of the company may have heard that sentiment before, there are reasons to see this moment as different – as more urgently promising.

 

Spring is in the Air

In HMPQ’s case, business is picking back up, and the company has reportedly stored up an inventory of top-tier products that is ready to be monetized. The company has also just launched its new ecommerce platform to help with that process, complete with an active payment processor capable of taking major credit and debit cards seamlessly, which is a major accomplishment.

“The new website has been designed to offer the ultimate user-friendly experience with an improved ease of use and functionality while allowing customers to see the wide variety of full-spectrum CBD oils the Company offers. We upgraded the website with our customers in mind, the site includes more information about our products such as our COAs, to help buyers find the right CBD product they need, and to instill better Confidence in this age of uncertainty,” stated Company CEO Sal Rosillo.

Note, according to its most recent release, the company wasn’t able to process orders due to a change in Policy with the PayPal Platform not allowing Hemp related product sales. The company has retained an Industry-leading payment processor that accepts payment for Hemp products. The company is very pleased to have been approved to accept credit cards through First Direct Financial.

That’s an enormous plus. The company’s web presence is live and active, and first-rate. And it has the capacity to do business with customers in convenient terms. In this case, that’s a biggie.

HempAmericana Inc (OTCMKTS:HMPQ) bills itself as an emerging player in the hemp-based CBD marketplace. The company also researches, develops and sells products made of industrial hemp, in addition to carrying out other non-hemp based products but intends to focus primarily on the potential for hemp.

In essence, anything that can be made with plastic can be made with industrial hemp and HempAmericana plans to fill the growing need and demand for hemp-based products within the United States. The company also intends to explore other possible business avenues relating to the legal use of the Cannabis plant.

But the big one right now is clearly about establishing scaling growth in its CBD-based products segment. There is every reason to believe we may be witnessing the roots of that right now, and in concert with the roots taking hold for an overall bottoming of the cannabis, hemp, and CBD market as a whole.

This article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.

Business

Singlepoint Inc. (OTCMKTS: SING) In A Joint Venture With Box Biosciences To Produce and Distribute Hand Sanitizers

Published

on

Singlepoint Inc. (OTCMKTS:SING) has formed a joint venture with BOX Biosciences to distribute various hand-sanitizer products produced in Carlsbad, California.

Singlepoint joint venture producing FDA-approved sanitizer

The two companies are distributing the FDA-approved sanitizer products on the west and east coast. BOX Biosciences is headquartered in Charleston, South Carolina, with distribution outlets in Raleigh, North Carolina, and Carlsbad, California. Following the coronavirus outbreak, there has been a shortage of disinfectant and sanitizer products.

Because of the urgent need to fill this shortage, the companies through the joint venture are working to ensure the US is safe by producing bulk hand sanitizers. They will also introduce disinfectants as permitted by the demand of hand sanitizers. Already the companies have on-going sales to various retail outlets, and currently, they are in discussions for potential hand sanitizer product sales.

The sanitizers the companies are manufacturing kill 99.9% of coronavirus causing germs, and they will be available to the general public and essential businesses. For now, the companies have prioritized the sanitizers to nursing homes, clinics, hospitals, government units, and home healthcare agencies. Equally essential businesses will also get prioritized in getting the bulk hand sanitizers.

Singlepoint and Box committed to offering solutions to COVID-19

Ryan Cowell, the founder of BOX Biosciences, indicated that they will focus on bulk orders of 250 gallons, 55-gallon drums, 1 gallon, 1 liter, 32oz, and 8oz totes of sanitizer. For businesses having the ability to offload bulk sanitizer from tankers, they can also order.

Singlepoint and Box’s expansion to making disinfectant and hand sanitizers shows how companies are dedicated to offering significant well-being solutions for the environment, surfaces, and people in response to the COVID-19 outbreak.

BOX’s operations manager Troy Lorenz stated there is an urge by businesses and people to clean and disinfect their work environment, and as a result, the products they are producing are important for the environment and people. The objective of Singlepoint and Box is to help authorities and people in combating the spread of COVID-19.

Continue Reading

Business

Sproutly Canada Inc (OTCMKTS:SRUTF) Chalks Out A Business Strategy To Focus On Commercialization Of APP Technology

Published

on

Sproutly Canada Inc (OTCMKTS:SRUTF) has chalked out a business transformation strategy to focus on commercializing its proprietary APP technology by moving away from cannabis cultivation resources. Infusion Biosciences Inc will contribute additional funds to implement business transformation. It will also supply additional talent to support the transformation plan.

Business transformation strategy

As part of the light technology model, Sproutly will focus on generating revenues through establishing ingredient supply agreements, technology licensing, and partnership opportunities. It will scale down the cultivation of cannabis, which is capital intensive, and reduce cash burn.

Sproutly has recruited Dr. Anup Sen as Chief Executive Officer for implementing a business transformation plan. Anup is the first scientist to invent water soluble CBD in cannabis plants. Following the appointment of Dr. Anup, Keith Dolo is relinquishing the post of CEO. Keith will also step down from the board of Sproutly. He will act as an advisor to the Chairman. Keith said the company’s main target is to introduce unique products in the market by using APP Technology. Sproutly also slashed cash expenses by giving pink slips to operational and corporate staff.

Sproutly is adopting the new business strategy because of the operational challenges and headwinds in the industry. Prohibitive costs associated with cannabis cultivation have forced the company to change its business strategy.

Commercializes APP technology

Sproutly will focus on APP technology commercialization through formulation, production, and the sale of ingredients by using Bi-Natural Oils and water-soluble cannabinoids. The company will use the licensed manufacturers’ distribution networks and its existing infrastructure to realize its revised plan. Sproutly has faced bottlenecks in introducing cannabis 2.0 products because it has earmarked human resources and significant capital for cannabis cultivation.

Adopts cost-cutting measures

Sproutly has reduced the employees by 75% to reduce costs and reduce cannabis cultivation. It has eased the capital requirements for Sproutly and pursues other strategic alternatives. The company will get the support of six key personnel of Infusion Biosciences to assist in its daily operations.

Infusion Biosciences’s key executives have helped Sproutly in obtaining licenses for APP technology and in forming partnerships in the US. Sproutly also expects to expedite its commercialization efforts with the help of these executives.

Continue Reading

Business

Aleafia Health Inc (OTCMKTS:ALEAF) Reports An Astonishing 2,486% Rise In Q1 2020 Revenues

Published

on

Aleafia Health Inc (OTCMKTS:ALEAF) has reported revenues of $14.59 million in Q1 2020. It is an increase of 2,486% compared to the same period last year and a 143% increase compared to the previous quarter.

Reports solid growth for the fifth consecutive quarter

Geoffrey Benic, Chief Executive Officer of Aleafia, said the company achieved a breakthrough in Q1 2020 on the backdrop of sustainable and disciplined growth. As it builds the cannabis wellness and health ecosystem, the company gives importance to the patient-centric approach. It is the fifth consecutive quarter to report solid growth.

Expects to introduce new cannabis 2.0 products in H2

Aleafia expects to introduce new cannabis 2.0 products tailored for the wellness and health consumers in H2, 2020. Its active registered patient count has surged to 10,983 as of March 31, 2020, from 10,249 as of December 31, 2019.

Key achievements in Q1 2020

Aleafia on March 26, 2020, announced plans to introduce direct-to-door medical cannabis delivery service to the registered patients. It is a contactless and safe delivery mechanism for the patients. Therefore, Aleafia eliminates the need for collecting the products from post boxes and post offices.

Achievements after Q1 2020

According to the announcement on May 1, 2020, Glenn Washer and Rhonda Lawson will be appointed to the board with effect from May 16, 2020. It is on the backdrop of the resignation of the existing directors – Bill Stewart, and Raf Souccar with effective from May 15, 2020. Julian Fantino, Chairman, has also resigned from the board.

Aleafia has temporarily shut down its physical offices of the education centers and cannabis clinics across the nation since March 16, 2020, because of the ongoing coronavirus crisis. The company is completing the patient consultations via its virtual clinics.

To maintain long term success, the company maintains a diversified portfolio of differentiated and high-quality product formats. The company will use in-house facilities to manufacture cannabis 2.0 products and satisfy the demand in the medical and adult-use cannabis markets in Canada. It will also supply cannabis 2.0 products in markets worldwide where legally permitted.

Aleafia Farms Inc, a wholly-owned subsidiary of Aleafia, has secured an amended license from Health Canada on May 12, 2020, for the outdoor cultivation at its Port Perry Facility.

Continue Reading
Advertisement

Whats Hot